Skip to content

Effect of Homoeopathic Medicine in the Treatment of Obsessive-Compulsive Disorder

Effect of Individualized Homoeopathic Medicine in the Treatment of Obsessive-Compulsive Disorder:an open observational non-randomized clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056405
Enrollment
45
Registered
2023-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F428- Other obsessive-compulsive disorder

Interventions

Intervention1: Individualized Homoeopathic Medicine: (a)Individualized homoeopathic medicine prescribed by using repertory of homoeopathic materia medica.(b)Remedies selected will be prescribed in 50

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients fulfilling the diagnostic criteria of OCD. 2) Patients of age group between10 to 60 years of age. 3) Patients from all religions. 4) Patients of both sexes. 5) Patients giving written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Patients unwilling to participate in the study. 2) Patients suffering from any life threatening illness or serious illnesses. 3) Substance abuse and/or dependence. 4) Pregnant women, lactating mothers, and women who are planning for pregnancy. 5) Patient who is suffering from schizophrenia.

Design outcomes

Primary

MeasureTime frame
Yale brown obsessive compulsive scale test scoreTimepoint: The yale brown obsessive compulsive test Questionnaire administered at base line, after 3 months and 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Prasanta Rath

National Institute of Homoeopathy

drprasantarath09@gmail.com8420924836

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026